Zobrazeno 1 - 10
of 2 941
pro vyhledávání: '"Loghavi, S."'
Autor:
El Chaer F; Department of Medicine, Division of Hematology and Oncology, University of Virginia, Charlottesville, VA, USA., Perissinotti AJ; Department of Clinical Pharmacy, Michigan Medicine and the University of Michigan College of Pharmacy, Ann Arbor, MI, USA., Loghavi S; Department of Leukemia and Hematopathology, The University of Texas, MD Anderson, Houston, TX, USA., Zeidan AM; Section of Hematology, Department of Internal Medicine, Yale School of Medicine and Yale Comprehensive Cancer Center, Yale University, New Haven, CT, USA. amer.zeidan@yale.edu.
Publikováno v:
Leukemia [Leukemia] 2024 Nov 05. Date of Electronic Publication: 2024 Nov 05.
Autor:
Loghavi S; Department of Hematopathology, The University of Texas, MD Anderson Cancer Center, Houston, Texas, USA., Wei Q; Department of Hematopathology, The University of Texas, MD Anderson Cancer Center, Houston, Texas, USA., Ravandi F; Department of Leukemia, The University of Texas, MD Anderson Cancer Center, Houston, Texas, USA., Quesada AE; Department of Hematopathology, The University of Texas, MD Anderson Cancer Center, Houston, Texas, USA., Routbort MJ; Department of Hematopathology, The University of Texas, MD Anderson Cancer Center, Houston, Texas, USA., Hu S; Department of Hematopathology, The University of Texas, MD Anderson Cancer Center, Houston, Texas, USA., Toruner GA; Department of Hematopathology, The University of Texas, MD Anderson Cancer Center, Houston, Texas, USA., Wang SA; Department of Hematopathology, The University of Texas, MD Anderson Cancer Center, Houston, Texas, USA., Wang W; Department of Hematopathology, The University of Texas, MD Anderson Cancer Center, Houston, Texas, USA., Miranda RN; Department of Hematopathology, The University of Texas, MD Anderson Cancer Center, Houston, Texas, USA., Li S; Department of Hematopathology, The University of Texas, MD Anderson Cancer Center, Houston, Texas, USA., Xu J; Department of Hematopathology, The University of Texas, MD Anderson Cancer Center, Houston, Texas, USA., DiNardo CD; Department of Leukemia, The University of Texas, MD Anderson Cancer Center, Houston, Texas, USA., Daver N; Department of Leukemia, The University of Texas, MD Anderson Cancer Center, Houston, Texas, USA., Kadia TM; Department of Leukemia, The University of Texas, MD Anderson Cancer Center, Houston, Texas, USA., Issa GC; Department of Leukemia, The University of Texas, MD Anderson Cancer Center, Houston, Texas, USA., Kantarjian HM; Department of Leukemia, The University of Texas, MD Anderson Cancer Center, Houston, Texas, USA., Medeiros LJ; Department of Hematopathology, The University of Texas, MD Anderson Cancer Center, Houston, Texas, USA., Tang G; Department of Hematopathology, The University of Texas, MD Anderson Cancer Center, Houston, Texas, USA.
Publikováno v:
American journal of hematology [Am J Hematol] 2024 Oct; Vol. 99 (10), pp. 1959-1968. Date of Electronic Publication: 2024 Jul 17.
Autor:
Nahmod KA; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Sasaki K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Ok CY; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Loghavi S; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Publikováno v:
American journal of hematology [Am J Hematol] 2024 Feb; Vol. 99 (2), pp. 329-330. Date of Electronic Publication: 2023 May 27.
Autor:
Senapati J; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Loghavi S; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX., Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Tang G; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX., Kadia T; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Short NJ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Abbas HA; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Arani N; Department of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX., DiNardo CD; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Borthakur G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Pemmaraju N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Oran B; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX., Shpall E; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX., Popat U; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX., Champlin R; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX., Pierce S; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Arora S; Department of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX., Issa G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Yilmaz M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Patel K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Takahashi K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Montalban-Bravo G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Hammond D; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Haddad FG; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Ravandi F; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Kantarjian HM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Daver NG; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX. ndaver@mdanderson.org.
Publikováno v:
Haematologica [Haematologica] 2024 Dec 12. Date of Electronic Publication: 2024 Dec 12.
Autor:
Jen WY; The University of Texas MD Anderson Cancer Center, Houston, Texas, United States., Sasaki K; The University of Texas MD Anderson Cancer Center, Houston, Texas, United States., Ravandi F; University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States., Kadia TM; MD Anderson Cancer Center, Houston, Texas, United States., Wang SA; UT MD Anderson Cancer Center, Houston, Texas, United States., Wang W; MD Anderson Cancer Center, Houston, Texas, United States., Loghavi S; The University of Texas, MD Anderson Cancer Center, Houston, Texas, United States., Daver NG; University of Texas, MD Anderson Cancer Center, Houston, Texas, United States., DiNardo CD; The University of Texas MD Anderson Cancer Center, Houston, Texas, United States., Issa GC; The University of Texas MD Anderson Cancer Center, Houston, Texas, United States., Abbas HA; M D Anderson Cancer Center, Houston, Texas, United States., Nasnas C; The University of Texas MD Anderson Cancer Center, Houston, Texas, United States., Bataller A; The University of Texas MD Anderson Cancer Center, Houston, Texas, United States., Urrutia S; Washington University in St. Louis School of Medicine, Saint Louis, Missouri, United States., Karrar OS; The University of Texas MD Anderson Cancer Center, Houston, Texas, United States., Pierce SA; UT MDACC, Houston, Texas, United States., Kantarjian HM; The University of Texas MD Anderson Cancer Center, Houston, Texas, United States., Short NJ; University of Texas MD Anderson Cancer Center, Houston, Texas, United States.
Publikováno v:
Blood advances [Blood Adv] 2024 Dec 04. Date of Electronic Publication: 2024 Dec 04.
Autor:
Dimopoulos YP; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Wang W; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Wang SA; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Loghavi S; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., DiNardo CD; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Gerstein Y; Clinical Cancer Genetics Program, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Hu S; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Tang Z; Department of Pathology, Microbiology, and Immunology, University of Nebraska Medical Center, Omaha, Nebraska, USA., Ilagan CJL; Department of Anatomic Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Thakral B; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., El Hussein S; Department of Pathology, The University of Vermont Medical Center, Burlington, Vermont, USA., Xu J; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Li S; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Lin P; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Patel KP; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Ok CY; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Medeiros LJ; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Fang H; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Publikováno v:
American journal of hematology [Am J Hematol] 2024 Dec; Vol. 99 (12), pp. 2416-2419. Date of Electronic Publication: 2024 Oct 11.
Autor:
Haddad FG; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Sasaki K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Senapati J; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Xiao L; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX., Park G; Department of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, TX., Abuasab T; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Venugopal S; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Rivera D; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Bazinet A; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Babakhanlou R; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Kim K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Ong F; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Desikan S; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Pemmaraju N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Loghavi S; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX., Borthakur G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., DiNardo C; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Abbas HA; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Short NJ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Daver N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Jabbour E; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Ravandi F; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Kantarjian H; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Kadia T; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
Publikováno v:
JCO oncology practice [JCO Oncol Pract] 2024 Dec; Vol. 20 (12), pp. 1637-1644. Date of Electronic Publication: 2024 Jul 16.
Autor:
Fiskus W; MD Anderson Cancer Center, Houston, Texas, United States., Mill CP; MD Anderson Cancer Center, Houston, Texas, United States., Bose P; University of Texas MD Anderson Cancer Center, Houston, Texas, United States., Masarova L; The University of Texas MD Anderson Cancer Center, Houston, Texas, United States., Pemmaraju N; The University of Texas MD Anderson Cancer Center, Houston, Texas, United States., Dunbar A; MD Anderson Cancer Center, Houston, Texas, United States., Birdwell C; MD Anderson Cancer Center, Houston, Texas, United States., Davis JA; MD Anderson Cancer Center, Houston, Texas, United States., Das K; UT MD Anderson Cancer Center, Houston, Texas, United States., Hou H; UT MD Anderson Cancer Center, Houston, Texas, United States., Manshouri T; MD Anderson Cancer Center, Houston, Texas, United States., Jain A; Baylor College of Medicine, Houston, Texas, United States., Malovannaya A; Baylor College of Medicine, Houston, Texas, United States., Philip K; MD Anderson Cancer Center, Houston, Texas, United States., Alhamadani N; MD Anderson Cancer Center, Houston, Texas, United States., Matthews A; MD Anderson Cancer Center, Houston, Texas, United States., Lin K; MD Anderson Cancer Center, Houston, Texas, United States., Flores L; UT MD Anderson Cancer Center, Houston, Texas, United States., Loghavi S; The University of Texas, MD Anderson Cancer Center, Houston, Texas, United States., DiNardo CD; The University of Texas MD Anderson Cancer Center, Houston, Texas, United States., Su X; MD Anderson Cancer Center, Houston, Texas, United States., Rampal RK; Memorial Sloan-Kettering Cancer Center, New York, New York, United States., Bhalla KN; MD Anderson Cancer Center, Houston, Texas, United States.
Publikováno v:
Blood [Blood] 2024 Nov 19. Date of Electronic Publication: 2024 Nov 19.
Autor:
Rodriguez-Sevilla JJ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Adema V; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Chien KS; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Loghavi S; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ma F; Department of Molecular, Cell and Developmental Biology, University of California Los Angeles, Los Angeles, CA, USA., Yang H; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Montalban-Bravo G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Huang X; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Calvo X; Laboratori de Citologia Hematològica, Servei de Patologia, Grup de Recerca Translacional Neoplàsies Hematològiques (GRETNHE), Hospital del Mar Research Institute (IMIM), Barcelona, Spain., Joseph J; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Bodden K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Colla S; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. scolla@mdanderson.org.
Publikováno v:
Nature communications [Nat Commun] 2024 Nov 13; Vol. 15 (1), pp. 9840. Date of Electronic Publication: 2024 Nov 13.
Autor:
Komrokji RS; Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Lanino L; Center for Accelerating Leukemia/Lymphoma Research at Comprehensive Cancer Center, IRCCS Humanitas Research Hospital, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Milan, Italy., Ball S; Division of Hematology and Oncology, Vanderbilt Ingram Cancer Center and Vanderbilt University School of Medicine, Nashville, TN, USA., Bewersdorf JP; Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Marchetti M; Azienda Ospedaliera Nazionale SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy., Maggioni G; Center for Accelerating Leukemia/Lymphoma Research at Comprehensive Cancer Center, IRCCS Humanitas Research Hospital, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Milan, Italy., Travaglino E; IRCCS Polilcinico San Matteo, Pavia, Italy., Al Ali NH; Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Fenaux P; Saint Louis Hospital, Paris Cité University, Paris, France., Platzbecker U; University Hospital Leipzig, Leipzig, Germany., Santini V; University of Florence, Florence, Italy., Diez-Campelo M; Haematology Department, University Hospital Salamanca, Salamanca, Spain., Singh A; Cleveland Clinic, Cleveland, OH, USA., Jain AG; Cleveland Clinic, Cleveland, OH, USA., Aguirre LE; Dana Farber Cancer Institute, Boston, MA, USA., Tinsley-Vance SM; Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Schwabkey ZI; Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Chan O; Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Xie Z; Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Brunner AM; Dana Farber Cancer Institute, Boston, MA, USA., Kuykendall AT; Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Bennett JM; University of Rochester Medical Center, Rochester, NY, USA., Buckstein R; Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada., Bejar R; University of California San Diego, San Diego, CA, USA., Carraway HE; Cleveland Clinic, Cleveland, OH, USA., DeZern AE; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, MD, USA., Griffiths EA; Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Halene S; Hematology Section, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA., Hasserjian RP; Massachusetts General Hospital, Boston, MA, USA., Lancet J; Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., List AF; Precision BioSciences, Durham, NC, USA., Loghavi S; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Odenike O; Leukemia Program, University of Chicago Medicine and University of Chicago Comprehensive Cancer Center, Chicago, IL, USA., Padron E; Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Patnaik MM; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA., Roboz GJ; New York-Presbyterian/Weill Cornell Medicine, New York, NY, USA., Stahl M; Dana Farber Cancer Institute, Boston, MA, USA., Sekeres MA; Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA., Steensma DP; Ajax Therapeutics, Cambridge, MA, USA., Savona MR; Division of Hematology and Oncology, Vanderbilt Ingram Cancer Center and Vanderbilt University School of Medicine, Nashville, TN, USA., Taylor J; Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA., Xu ML; Department of Pathology and Laboratory Medicine, Yale School of Medicine, New Haven, CT, USA., Sweet K; Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Sallman DA; Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Nimer SD; Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA., Hourigan CS; Virginia Tech FBRI Cancer Research Center, Washington, DC, USA., Wei AH; Department of Haematology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Sauta E; Center for Accelerating Leukemia/Lymphoma Research at Comprehensive Cancer Center, IRCCS Humanitas Research Hospital, Milan, Italy., D'Amico S; Center for Accelerating Leukemia/Lymphoma Research at Comprehensive Cancer Center, IRCCS Humanitas Research Hospital, Milan, Italy; Train, Milan, Italy., Asti G; Center for Accelerating Leukemia/Lymphoma Research at Comprehensive Cancer Center, IRCCS Humanitas Research Hospital, Milan, Italy., Castellani G; Department of Medical and Surgical Sciences-DIMEC, University of Bologna, Bologna, Italy., Delleani M; Center for Accelerating Leukemia/Lymphoma Research at Comprehensive Cancer Center, IRCCS Humanitas Research Hospital, Milan, Italy., Campagna A; Center for Accelerating Leukemia/Lymphoma Research at Comprehensive Cancer Center, IRCCS Humanitas Research Hospital, Milan, Italy., Borate UM; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA., Sanz G; Instituto de Salud Carlos III, Valencia, Spain., Efficace F; Department of Haematology, La Fe University and Polytechnic Hospital, Valencia, Spain., Gore SD; Division of Cancer Prevention, National Cancer Institute, Rockville, MD, USA., Kim TK; Division of Hematology and Oncology, Vanderbilt Ingram Cancer Center and Vanderbilt University School of Medicine, Nashville, TN, USA., Daver N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Rozman M; Hospital Clínic Barcelona, Barcelona, Spain., Orfao A; Haematology Department, University Hospital Salamanca, Salamanca, Spain., Wang SA; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Foucar MK; University of New Mexico, Albuquerque, NM, USA., Germing U; Department of Haematology, Oncology, and Clinical Immunology, Heinrich Heine University, Düsseldorf, Germany., Haferlach T; MLL Munich Leukemia Laboratory, Munich, Germany., Scheinberg P; Beneficência Portuguesa de São Paulo Hospital, São Paulo, Brazil., Miyazaki Y; Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan., Iastrebner M; Sanatorio Sagrado Corazón, Buenos Aires, Argentina., Kulasekararaj A; King's College Hospital NHS Foundation Trust, NIHR/Wellcome King's Clinical Research Facility, London, UK., Cluzeau T; Nice University Hospital, Nice, France., Kordasti S; Comprehensive Cancer Centre, School of Cancer and Pharmaceutical Sciences, King's College, London, UK., van de Loosdrecht AA; Department of Hematology, Amsterdam University Medical Center, VU University Medical Center-Cancer Center, Amsterdam, Netherlands., Ades L; Saint Louis Hospital, Paris Cité University, Paris, France., Zeidan AM; Hematology Section, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA., Della Porta MG; Center for Accelerating Leukemia/Lymphoma Research at Comprehensive Cancer Center, IRCCS Humanitas Research Hospital, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Milan, Italy. Electronic address: matteo.della_porta@hunimed.eu.
Publikováno v:
The Lancet. Haematology [Lancet Haematol] 2024 Nov; Vol. 11 (11), pp. e862-e872. Date of Electronic Publication: 2024 Oct 09.